SickKids Researchers Map Atomic ‘Wire’ That Powers Tuberculosis Survival and Antibiotic Resistance

SickKids researchers uncover the 3D structure of EtfD, the protein "wire" TB bacteria use to fuel themselves, opening doors to shorter, more effective treatments.

By: AXL Media

Published: Mar 17, 2026, 7:38 AM EDT

Source: Information for this article was sourced from The Hospital for Sick Children (SickKids)

Decoding the Survival Strategy of a Global Killer

Tuberculosis remains the leading cause of death by infectious disease worldwide, a status maintained by the bacterium’s sophisticated ability to enter a dormant state within the human body. During infection, Mycobacterium tuberculosis creates lipid-rich environments in the lungs, feeding on fats from damaged cells to fuel its persistence. This metabolic shift allows the bacteria to survive for long periods, becoming increasingly tolerant to antibiotics and necessitating grueling treatment courses. According to Dr. John Rubinstein, understanding this specific fueling mechanism is the first step toward dismantling the bacterium's defense against modern medicine.

The EtfD Protein: A Metabolic Connector

Utilizing high-resolution cryo-electron microscopy, the research team produced the first atomic-level model of the protein EtfD. The structure reveals that EtfD functions essentially as a biological wire. It bridges the gap between fatty acid metabolism and the electron transport chain, moving energy harvested from broken-down lipids into the system the bacterium uses to produce adenosine triphosphate (ATP). ATP is the universal energy currency that powers the bacterium's survival, making this "wire" an essential lifeline for the infection during its dormant phase.

A New Toolkit for Drug Discovery

Beyond mapping the structure, the study introduces the first biochemical assay capable of measuring EtfD activity in real-time. While EtfD had long been considered a promising drug target, researchers previously lacked the tools to observe it working or to quantify the effects of potential inhibitors. This new laboratory test allows scientists to see exactly when the wire-like pathway is active and, crucially, when it is successfully blocked. This combination of structural data and activity measurement provides a comprehensive toolkit for screening vast libraries of compounds to find the next generation of TB treatments.